ST. HELIER, JERSEY, 5 August 2015 – Novocure, a commercial stage oncology company, was selected today as one of the World Economic Forum’s “Technology Pioneers”, a recognition of the world’s most innovative companies. Novocure is developing a novel, proprietary therapy called TTFields for the treatment of solid tumor cancers. TTFields is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on key molecules inside cancer cells, disrupting the basic machinery necessary for normal cell division, leading to cancer cell death.

Novocure was chosen by a selection committee from among hundreds of candidates as one of 49 companies. Thanks to its selection, the company will have access to the one of the most influential and sought-after business and political networks in the world, and be invited to the World Economic Forum’s “Summer Davos” in Dalian, China, this September, and the Annual Meeting in Davos in January.

“We’re glad to see an oncology company make it to the selection,” says Fulvia Montresor, Head of Technology Pioneers at the World Economic Forum. “Novocure is part of a group of entrepreneurs who are more aware of the crucial challenges of the world around them, and who are determined to do their part to solve those challenges with their company.”
“Novocure’s selection by the World Economic Forum as a Technology Pioneer recognizes the tremendous contributions to the field of oncology of both Yoram Palti, MD, PhD, Novocure’s co- founder, professor emeritus at the Technion Institute of Technnology, and the inventor of TTFields therapy, and the Novocure team who transformed Palti’s idea into a commercial stage product,” commented Bill Doyle, Novocure’s Executive Chairman. “We believe TTFields will become an entirely new treatment modality for a variety of solid tumor cancers and we are proud that the World Economic Forum has recognized this important innovation.”

The Technology Pioneers were selected from among hundreds of applicants by a selection committee of 68 academics, entrepreneurs, venture capitalists and corporate executives. Notable members of the committee include Arianna Huffington (founder, Huffington Post) and Henry Blodget (editor-in-chief, Business Insider). The committee based its decisions on criteria including innovation, potential impact, working prototype, viability and leadership.

Past recipients include Google (2001), Wikimedia (2007), Mozilla (2007), Kickstarter (2011) and Dropbox (2011). More information on past winners can be found here.

More HCB News